Literature DB >> 3980697

Effect of adjuvant vaccines on dengue virus type 2 immune ascitic fluid production.

W C Gamble, E H George, M B Fears, D W Sanderlin, W A Chappell.   

Abstract

In a comparison of dengue type 2 immune mouse ascitic fluid immunization schedules, a schedule in which adjuvant vaccines were not used produced neutralizing antibody titers that were specific and a mouse mortality rate that was lower, resulting in a greater yield of ascitic fluids. In the schedules in which emulsified adjuvant vaccines were used, the quality of the emulsion had little effect on antibody titer produced.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3980697      PMCID： PMC271685          DOI： 10.1128/jcm.21.3.452-453.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  A SYRINGE CHURN FOR MAKING REPOSITORY EMULSIONS. ORIGINS, PRINCIPLES AND PERFORMANCE.

Authors:  S D LOCKEY; R H BERG
Journal:  Ann Allergy       Date:  1964-08

2.  A simple device for making emulsified vaccines.

Authors:  B S BERLIN; R W McKINNEY
Journal:  J Lab Clin Med       Date:  1958-10

3.  Development of arthritis, periarthritis and periostitis in rats given adjuvants.

Authors:  C M PEARSON
Journal:  Proc Soc Exp Biol Med       Date:  1956-01

4.  Production and characterization of arbovirus antibody in mouse ascitic fluid.

Authors:  W E Brandt; E L Buescher; F M Hetrick
Journal:  Am J Trop Med Hyg       Date:  1967-05       Impact factor: 2.345

5.  Bacteriological and pathological study of animals given Freund adjuvant.

Authors:  R H Rigdon; T Schadewald
Journal:  Appl Microbiol       Date:  1972-10

6.  New metabolizable immunologic adjuvant for human use. 8. Chronic toxicity and teratogenic tests.

Authors:  H M Peck; A F Woodhour; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1968-07

7.  The use of adjuvant and sarcoma 180 cells in the production of mouse hyperimmune ascitic fluids to arboviruses.

Authors:  E S Tikasingh; L Spence; W G Downs
Journal:  Am J Trop Med Hyg       Date:  1966-03       Impact factor: 2.345

8.  Use of sarcoma 180/TG to prepare hyperimmune ascitic fluid in the mouse.

Authors:  A C Sartorelli; D S Fischer; W G Downs
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

9.  A plaque reduction test for dengue virus neutralizing antibodies.

Authors:  P K Russell; A Nisalak; P Sukhavachana; S Vivona
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

10.  Comparison of immunization methods for producing reference adenovirus antisera in horses.

Authors:  J C Hierholzer; W C Gamble; K D Quist; W A Chappell
Journal:  Appl Microbiol       Date:  1972-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.